Request Deal Involvement

Biocon to acquire Biocon Biologics Limited from Serum Institute Life Sciences, Tata Capital, Activ Pine and Mylan for $6.315bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Morgan Stanley

financial advisors

Morgan Stanley

Hsbc

financial advisors

Hsbc

Ernst & Young

tax advisors

Ernst & Young

Shardul Amarchand Mangaldas & Co

legal advisors

Shardul Amarchand Mangaldas & Co

or

Principals

TATA CAPITAL

vendor

TATA CAPITAL

BIOCON LIMITED

bidder

BIOCON LIMITED

SERUM INSTITUTE OF INDIA

vendor

SERUM INSTITUTE OF INDIA

BIOCON BIOLOGICS LTD

target

BIOCON BIOLOGICS LTD

MYLAN NV

vendor

MYLAN NV

ACTIV PINE LLP

vendor

ACTIV PINE LLP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Biocon to acquire Biocon Biologics Limited from Serum Institute Life Sciences, Tata Capital, Activ Pine and Mylan for $6.315bn.